[go: up one dir, main page]

AU2003268353A1 - Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection - Google Patents

Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection

Info

Publication number
AU2003268353A1
AU2003268353A1 AU2003268353A AU2003268353A AU2003268353A1 AU 2003268353 A1 AU2003268353 A1 AU 2003268353A1 AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A1 AU2003268353 A1 AU 2003268353A1
Authority
AU
Australia
Prior art keywords
diagnosis
prevention
treatment
streptococcus pneumoniae
active infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003268353A
Other versions
AU2003268353A8 (en
Inventor
Andrew Camilli
David L. Hava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tufts University
Original Assignee
Tufts University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts University filed Critical Tufts University
Publication of AU2003268353A8 publication Critical patent/AU2003268353A8/en
Publication of AU2003268353A1 publication Critical patent/AU2003268353A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003268353A 2002-08-30 2003-09-02 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection Abandoned AU2003268353A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40708202P 2002-08-30 2002-08-30
US60/407,082 2002-08-30
PCT/US2003/027401 WO2004020609A2 (en) 2002-08-30 2003-09-02 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection

Publications (2)

Publication Number Publication Date
AU2003268353A8 AU2003268353A8 (en) 2004-03-19
AU2003268353A1 true AU2003268353A1 (en) 2004-03-19

Family

ID=31978415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003268353A Abandoned AU2003268353A1 (en) 2002-08-30 2003-09-02 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection

Country Status (2)

Country Link
AU (1) AU2003268353A1 (en)
WO (1) WO2004020609A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0407384A (en) 2003-02-14 2006-02-21 Pfizer Prod Inc pyridines-triazoles as anti-inflammatory compounds
WO2006048757A2 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
WO2006048753A2 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
US8722055B2 (en) * 2006-09-27 2014-05-13 St. Jude Children's Research Hospital Synthetic Streptococcus pneumoniae vaccine
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
JP5697991B2 (en) 2008-02-01 2015-04-08 サノフィ パストゥール リミテッドSanofi Pasteur Limited Diagnostic assays
MX2012000158A (en) 2009-06-29 2012-06-08 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae.
AU2011336366B2 (en) 2010-12-03 2016-05-12 Sanofi Pasteur Limited Composition for immunization against Streptococcus pneumoniae
AU2012207088A1 (en) 2011-01-20 2013-05-02 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae
EP2817320A1 (en) * 2012-02-24 2014-12-31 Novartis AG Pilus proteins and compositions
WO2017091707A1 (en) * 2015-11-25 2017-06-01 Wake Forest University Health Sciences Pneumococcal inhibitory factor compositions and methods of use thereof
CA3111459A1 (en) * 2018-09-12 2020-03-19 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420135B1 (en) * 1996-10-31 2002-07-16 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences

Also Published As

Publication number Publication date
WO2004020609A9 (en) 2004-05-13
AU2003268353A8 (en) 2004-03-19
WO2004020609A3 (en) 2004-07-15
WO2004020609A2 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2001280702A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
AU2002255248A1 (en) Diagnosis, treatment and research of mental disorders
HK1049656A1 (en) Fab i inhibitors
WO2003088897A3 (en) Fab i inhibitors
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2003268353A1 (en) Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
WO2000058475A3 (en) Streptococcus pneumoniae antigens
AU2002239485A1 (en) Methods for improved diagnosis and treatment of mycobacterial infections
WO2003009859A1 (en) Immunotherapy for humans
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2003261782A1 (en) Bacteriophages and remedies for bacterial infection
AU2003210266A1 (en) Treatment, diagnosis and imaging of disease
AU2003247841A1 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
WO2003065979A3 (en) Methods of diagnosis, monitoring and treatment of fertility
AU2001292943A1 (en) Prevention and treatment of streptococcal and staphylococcal infection
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU2002367861A1 (en) Prevention and treatment of streptococcal and staphylococcal infection
ZA200108013B (en) Monthly closes for treatment of Streptococcus pneumoniae infections.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase